To monitor the health of patients undergoing or recovering from heart surgery, the Instituto do Coração of the Hospital das Clínicas of the Faculty of Medicine of the University of São Paulo (InCor) is expected to manufacture the Galaxy Watch 4, from Samsung, available to some people. The experiment is sponsored by the South Korean technology company.
Initially, the project involving cardiac patients should last 14 months and will test assisted digital remote monitoring in practice. The volunteers will share different clinical signs, through the use of the smartwatch, such as heartbeat intensity.
Who should use the Galaxy Watch 4 in the experiment?
According to the research announcement, the Galaxy Watch 4 will be worn by preoperative and postoperative patients. Among the vital signs collected, those responsible for the experiment highlight:
- Arterial pressure;
- Oxygen saturation;
- sleep pattern;
From the follow-up of these data, it will be possible to identify the possible risks for the health of the patients. In the event of a relevant change, the medical team can adopt early interventions and invite users to a battery of examinations, for example. As a result, more serious complications should be avoided.
How will patient information be controlled?
The information captured by the smartwatch must be stored on a highly secure data platform, developed by InCor’s medical, multi-professional, technology and innovation teams, including InovaInCor.
In this process, Samsung will act in the data collection module of smartwatches, used in research. This module was developed by the Research and Development department of Samsung Brasil, located in Campinas, inside São Paulo.
What are the prospects for the partnership with the hospital?
It should be explained that more than 100,000 heart surgeries are performed in Brazil every year, according to the Brazilian Society of Cardiovascular Surgery (Sbccv). In other words, the potential demand for this type of monitoring could be high if the results are promising.
Among the potential benefits is a shorter hospital stay after the procedure, as the patient will continue to be followed at home, as explained by physician Fabio Jatene, director of the cardiovascular surgery division of InCor.
“We are taking an innovative step in medicine, which we hope will contribute significantly to the value of health for the patient, significantly improving their experience of care,” Jatene said in a statement.
“The objective of this research project is to allow patients to be assisted, subject to prior authorization, thanks to the data collected by the Galaxy Watch. This platform will allow them to continue to be followed during their treatment, even outside the hospital environment, facilitating the identification of possible risk situations and allowing preventive medical actions”, reinforces Luis Guilherme Selber, head of innovation at the Research and Development area at Samsung Brazil.
Despite the functions of this watch and other similar models, it should be noted that the information generated is only intended for the purposes of general well-being and physical activity. Thus, the measurements should not be used to conclude a diagnosis or to define a medical treatment, but they can be a means of screening for possible complications.